Daewoong pharmaceutical Co.,Ltd (069620.KS) KSC
123,000.00
-4200(-3.30%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
123,000.00
-4200(-3.30%)
Currency In KRW
Address
12, Bongeunsa-ro 114-gil
Seoul, 135-715
Korea (the Republic of)
Phone
82 2 550 8209
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1727
First IPO Date
September 29, 2005
| Name | Title | Pay | Year Born |
| Chang-Jae Lee | Chief Executive Officer & Executive Director | 650M | 1977 |
| Seongsoo Park | Chief Executive Officer & Executive Director | 650M | 1976 |
| Eunkyeong Park | Executive Director | 0 | N/A |
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.